Introduction The Human Tissue Authority (HTA) is the national independent regulator for organisations that remove, store and use tissue for research, medical treatment, post-mortem examination, teaching and display in public. We also give approval for organ and bone marrow donations from living people. With the interests of the public and those we regulate at the centre of our work, we aim to maintain confidence by ensuring that human tissue is used safely and ethically, with proper consent. Established under the Human Tissue Act (2004), we are an Executive Non-Departmental Public Body (ENDPB) sponsored by the Department of Health. The Authority’s Chair and members are appointed by the Secretary of State for Health. The Chair and half of the members are lay, with the remainder being professionals drawn from some of the groups who are affected by the legislation. The Authority is supported by an Executive team of 50 staff. The HTA’s primary goal is to protect public and professional confidence in the safe and ethical use of human tissue. The HTA has developed an ambitious vision and strategy for the next three years centred on achieving greater sustainability, agility and resilience in our operations. Since the onset of the COVID-19 pandemic, the HTA has brought forward a number of changes already identified in the Development Programme. A key driver of the Development Programme is the HTA’s aim to be a data driven regulator strengthening the role data and intelligence plays in our model and the regulatory offer to the sectors and establishments we license. The HTA is a member of both the Business in the Community Race and Work Charter and the Disability Confident Charter. The HTA is committed to ensuring an inclusive and supportive working environment that is free from any form of discrimination. We recognise that there are real benefits of having a diverse community of staff and the HTA aims for our workforce to be truly representative of all sections of society. Additionally, we adopt a culture that hopes to attract and retain talented individuals that want to work with us. Job Purpose The Policy Manager will both lead on and support colleagues to develop and draft HTA policies on a wide range of issues within the regulatory remit of the organisation. The role will be essential in ensuring the co-ordination of all regulatory development projects. The role will be responsible for ensuring that the HTA is forward looking in its policy development, and the successful candidate will be able to develop corporate and regulatory policy independently as well as supporting colleagues when they are developing policy. In particular, the role will need to work closely with the Heads of Regulation who play a key role in identifying areas of policy development for their sectors, and the implementation of policies. The successful candidate will support the Head of Development in their role. Specifically, key responsibilities will be: to ensure cross-sector co-ordination in the development of regulatory policy; to lead (or contribute to) regulatory policy development at the HTA, working closely with the Heads of Regulation for each sector; to support the Head of Development in any work required to implement legislative change and required developments to ways of working; to develop and maintain the HTA’s map of regulatory policies and advise on updates/changes as appropriate; to act as the hub for regulatory horizon scanning and make recommendations for new policies; to work with the Head of Development to ensure that regulatory policies are aligned with corporate policies; to provide advice and guidance on HTA policy issues to colleagues and external stakeholders; and, to strengthen external partnership working and engagement with other regulators, Arm’s Length Bodies (ALBs) and the wider life sciences sector. Please see attached for full .